Onlikon recently stated during an investigation by the agency that all three pipelines are currently in the pre-clinical PCC stage and are progressing according to the plan. From PCC to IND, it is necessary to complete candidate molecule confirmation, pharmacy, and non-clinical research. At the same time, the production time of autonomous ionizable lipids will also be combined with Cree Biotech's R&D and production progress. The entire cycle is greatly affected by the technical route and experimental results. Under normal circumstances, it takes about 1 to 1.5 years. Judging from the current experimental data, the targets of the three pipelines are relatively clear, and there is a certain probability that the drug will develop.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.